Cat. No. | Product name | CAS No. |
DC8336 |
Tizoxanide
Featured
Tizoxanide is a potent inhibitor of hepatitis B virus and hepatitis C virus. |
173903-47-4 |
DC8736 |
Tofacitinib
Featured
Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3. |
477600-75-2 |
DC5165 |
Tofacitinib (CP-690550) Citrate
Featured
Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3. |
540737-29-9 |
DC7826 |
Tofogliflozin hydrate
Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2). |
1201913-82-7 |
DC8008 |
TOK-001(Galeterone)
Featured
TOK-001 is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC). |
851983-85-2 |
DC11485 |
Tolcapone
Featured
Tolcapone is an orally active catechol-O-methyltransferase (COMT) inhibitor. |
134308-13-7 |
DC9148 |
Tolvaptan
Featured
Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. |
150683-30-0 |
DC7519 |
Torcetrapib
Featured
Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3. |
262352-17-0 |
DC9332 |
Tozadenant
Tozadenant (SYN-115) is an adenosine A2A receptor antagonist. |
870070-55-6 |
DC8223 |
TP-0903
Featured
TP-0903 is a a high-affinity Axl inhibitor with IC50 of 27 nM. |
1341200-45-0 |
DC10611 |
Trabectedin
Featured
Trabectedin (Ecteinascidin-743 or ET-743) is a novel antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo. |
114899-77-3 |
DC1099 |
Trametinib
Featured
Trametinib is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively. |
871700-17-3 |
DC6400 |
Tranilast (SB 252218)
Featured
Tranilast (SB 252218) |
53902-12-8 |
DC8824 |
Traxoprodil
Featured
Traxoprodil is an NMDA ε 2 (NR2B) antagonist that has been studied as an alternative to serotonin selective reuptake inhibitors. |
134234-12-1 |
DC7522 |
Triapine
Featured
Triapine is a potent ribonucleotide reductase inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis. Phase 2. |
143621-35-6 |
DC21567 |
Triazavirin (Riamilovir)
Featured
Triazavirin is a guanine nucleotide analog antiviral originally developed in Russia that has shown efficacy against influenza A and B, including the H5N1 strain. It appears that Triazavirin has shown promise in reducing influenza disease severity and associated complications.5 Given the similarities between SARS-CoV-2 and H5N1, health officials are investigating Triazavirin as an option to combat SARS-CoV-2, the coronavirus responsible for COVID-19. |
928659-17-0 |
DC9157 |
Trifluoperazine dihydrochloride
Trifluoperazine Dihydrochloride is a potent dopamine D2 receptor inhibitor used as an antipsychotic and an antiemetic. |
440-17-5 |
DC12037 |
Triptolide
Featured
Triptolide is the major bioactive constituent of T. wilfordii Hook F., also known as thunder god vine, a traditional Chinese medicinal herb with known antiproliferative, immunosuppressive, anti-inflammatory, antifertility, and anti-polycystic kidney disea |
38748-32-2 |
DC9538 |
TRO 19622
Featured
TRO19622, a small cholesterol-like molecule, is a neuroregenerative and neuroprotective compound. |
22033-87-0 |
DC11385 |
Trofinetide(NNZ2566)
Featured
Trofinetide (NNZ-2566) is an analog of a molecule which is derived from IGF-1 and occurs naturally in the brain. IGF-1 is a growth factor stimulated by growth hormone. |
853400-76-7 |
DC8903 |
Troglitazone
Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity. |
97322-87-7 |
DC10737 |
Tropifexor (LJN452)
Featured
Tropifexor (LJN452) is a highly potent non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH). |
1383816-29-2 |